Long-term follow-up of covered stent implantation for various coronary artery diseases

Daisuke Hachinohe1,2,3, Azeem Latib1,2,4, Alessandra Laricchia1

  • 1Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy.

Insights

Long-term follow-up of coronary covered stents (CS) shows early and increasing cardiac events. Implantation in coronary artery aneurysms (CAA) is safer than in coronary artery perforations (CAP) or saphenous vein grafts (SVG).

Area of Science:

  • Cardiovascular medicine
  • Interventional cardiology
  • Biomaterials in medicine

Background:

  • Limited long-term data exists for coronary covered stents (CS).
  • Previous studies have not compared CS outcomes based on specific lesion indications.

Purpose of the Study:

  • To assess long-term clinical outcomes following coronary covered stent (CS) implantation.
  • To compare CS outcomes across different indications, including saphenous vein graft (SVG), coronary artery perforation (CAP), and coronary artery aneurysm (CAA).

Main Methods:

  • Retrospective study of 190 patients (212 lesions) who received CS between May 1997 and February 2017.
  • Clinical outcomes were evaluated and compared using the Gehan-Breslow-Wilcoxon test.
  • Median follow-up duration was 6.0 years.

Main Results:

  • CS was primarily used for SVG (51.4%), CAP (25.0%), and CAA (11.8%).
  • Major adverse events like target vessel occlusion (16.6% at 1 year, 38.6% at 10 years) and stent thrombosis (8.9% at 1 year, 17.8% at 10 years) increased over time.
  • Outcomes were superior in CAA compared to CAP and SVG, with no target vessel MI, occlusion, or stent thrombosis observed in CAA.

Conclusions:

  • Coronary covered stent (CS) implantation is associated with early and progressively increasing clinical events.
  • CS implantation for coronary artery aneurysms (CAA) demonstrates favorable outcomes with fewer adverse events.
  • CS implantation for coronary artery perforation (CAP) and saphenous vein grafts (SVG) carries a significant risk of long-term cardiac events.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
420
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
249
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
364
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
663
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
375